<DOC>
	<DOCNO>NCT00316615</DOCNO>
	<brief_summary>The purpose study evaluate safety immunogenicity single intramuscular ( IM ) injection Surface Antigen , Inactivated , Influenza Vaccine , Formulation 2005-2006 , Administered Non-Elderly Adults Elderly Subjects</brief_summary>
	<brief_title>Safety Immunogenicity Inactivated Influenza Vaccine When Administered Non Elderly Adults Elderly Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>subject 18 year age older Any serious disease : cancer , autoimmune disease , advance arteriosclerotic disease complicate diabetes mellitus , chronic obstructive pulmonary disease ( COPD ) require oxygen therapy , acute progressive hepatic disease , acute progressive renal disease , congestive heart failure hypersensitivity egg , chicken protein , chicken feather , influenza viral protein , neomycin polymyxin component vaccine history neurological symptom sign , anaphylactic shock follow administration vaccine know suspect ( high risk develop ) impairment/alteration immune function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>influenza</keyword>
	<keyword>non elderly adult elderly</keyword>
	<keyword>vaccine</keyword>
</DOC>